Work

Phase II trial of single-agent cetuximab in patients with persistent or recurrent epithelial ovarian or primary peritoneal carcinoma with the potential for dose escalation to rash

Year: 2007

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2007.25.18_suppl.5577

Authors: R. J. Schilder, A. E. Lokshin, R. W. Holloway, R. D. Alvarez, H. Pathak, C. Aghajanian, C. W. Drescher, A. K. Godwin

Institutions: Fox Chase Cancer Center, Memorial Sloan Kettering Cancer Center, University of Alabama at Birmingham, Florida Hospital Cancer Institute, UPMC Hillman Cancer Center

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2297856782

Cites:

Cited by: 6

Related to: 10